Defective DNA repair in EGFR-mutant lung cancer
In patients with lung cancer whose tumors harbor activating mutations in the EGF receptor (EGFR), increased responses to platinum-based chemotherapies are seen compared with wild-type cancers. However, the mechanisms underlying this association have remained elusive. Here, we describe a cellular phe...
Main Author: | |
---|---|
Format: | Others |
Published: |
Ludwig-Maximilians-Universität München
2013
|
Subjects: | |
Online Access: | http://edoc.ub.uni-muenchen.de/16240/1/Pfaeffle_Heike_N.pdf http://nbn-resolving.de/urn:nbn:de:bvb:19-162407 |